78 related articles for article (PubMed ID: 31390662)
1. Clinical updates in adult immune thrombocytopenia.
Lambert MP; Gernsheimer TB
Blood; 2017 May; 129(21):2829-2835. PubMed ID: 28416506
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and therapeutic options in primary immune thrombocytopenia.
Stasi R
Blood Transfus; 2011 Jul; 9(3):262-73. PubMed ID: 21251458
[No Abstract] [Full Text] [Related]
3. Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.
Porcelijn L; Schmidt DE; van der Schoot CE; Vidarsson G; de Haas M; Kapur R
Haematologica; 2020 Apr; 105(4):e172-e174. PubMed ID: 31296573
[No Abstract] [Full Text] [Related]
4. Biologic immunomodulatory medications and autoimmune cytopenias: A cross-sectional analysis of a national surveillance database.
Bibb LA; Adkins BD; Stephens LD; Booth GS; Jacobs JW
J Am Acad Dermatol; 2024 Jul; 91(1):153-156. PubMed ID: 38513833
[No Abstract] [Full Text] [Related]
5. Autoimmune haematological disorders.
Provan D
Clin Med (Lond); 2001; 1(6):447-51. PubMed ID: 11792082
[No Abstract] [Full Text] [Related]
6. Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Palandri F; Rossi E; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Carrai V; Barcellini W; Patriarca A; Rivolti E; Consoli U; Cantoni S; Oliva EN; Chiurazzi F; Caocci G; Giuffrida G; Borchiellini A; Auteri G; Baldacci E; Carli G; Nicolosi D; Sutto E; Carpenedo M; Cavo M; Mazzucconi MG; Zaja F; De Stefano V; Rodeghiero F; Vianelli N
Blood; 2021 Aug; 138(7):571-583. PubMed ID: 33889952
[TBL] [Abstract][Full Text] [Related]
7. American Society of Hematology 2019 guidelines for immune thrombocytopenia.
Neunert C; Terrell DR; Arnold DM; Buchanan G; Cines DB; Cooper N; Cuker A; Despotovic JM; George JN; Grace RF; Kühne T; Kuter DJ; Lim W; McCrae KR; Pruitt B; Shimanek H; Vesely SK
Blood Adv; 2019 Dec; 3(23):3829-3866. PubMed ID: 31794604
[TBL] [Abstract][Full Text] [Related]
8. Immune Thrombocytopenia-A Disease or a Group of Disorders? Where Do We Stand in 2019?
Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):225-226. PubMed ID: 31390662
[No Abstract] [Full Text] [Related]
9. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R; Chaturvedi S
Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
[TBL] [Abstract][Full Text] [Related]
10. Immune Thrombocytopenia.
Cooper N; Ghanima W
N Engl J Med; 2019 Sep; 381(10):945-955. PubMed ID: 31483965
[No Abstract] [Full Text] [Related]
11. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and Therapy of Immune thrombocytopenia].
Matzdorff A; Wörmann B
Dtsch Med Wochenschr; 2018 Aug; 143(15):1076-1081. PubMed ID: 30060276
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
